Gaining entry to Retatrutide, the new medication for obesity treatment , currently presents a limitation for many. At present, it isn't readily obtainable in most areas . Limited clinical studies and a phased rollout are playing a role to this situation. Patients interested in receiving Retatrutide should speak with their healthcare provider to det